Partner David Simon was quoted in an Agenda article, “SEC, DOJ to Trim FCPA Enforcement in 2017.” The article discussed how new leadership at the SEC and DOJ in 2017 may impact enforcement at both agencies, particularly as it relates to prioritization of anti-bribery and corruption compliance. In reference to Jeff Sessions as the new attorney general, Simon said Sessions is viewed as a “prosecute or don’t prosecute kind of guy.” Under Sessions’ leadership, the DOJ could take a more black-and-white approach to the FCPA, issuing fewer deferred and non-prosecution agreements over gray-area cases, he said.
The article also focused on the DOJ’s FCPA pilot program and whether it will continue under the Trump administration. Simon said that, “My optimistic side says if the new administration is trying to make this more of a pro-business paradigm, they’ll actually take it further and build more certainty in.”
The article also focused on the DOJ’s FCPA pilot program and whether it will continue under the Trump administration. Simon said that, “My optimistic side says if the new administration is trying to make this more of a pro-business paradigm, they’ll actually take it further and build more certainty in.”
People
Related News
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."
July 24, 2025
In the News
Gregory Husisian and David Simon on Tariff Evasion – 'Huge money at stake'
Foley & Lardner LLP partners Gregory Husisian and David Simon detailed the rise and risks of tariff evasion in the POLITICO article, "As Trump raises tariffs, companies find ways to cheat — and risk getting caught."
July 23, 2025
In the News
Aaron Maguregui on AI Scribes in Health Care – 'Technically, it's a third party listening'
Foley & Lardner LLP partner Aaron Maguregui shared insights on the growing applications for artificial intelligence across health care in the healthleaders article, “Is Your AI Scribe HIPAA-Compliant?“